Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
:::

張俊欽 (Chun-Chin Chang)

[簡介]

  • 學歷
    國立陽明大學臨床醫學研究所
    國立陽明大學醫學士
  • 經歷
    現職:
    • - 迄今 臺北榮民總醫院 內科部心臟科 主治醫師
    • - 迄今 Taipei Veterans General Hospital Division of Cardiology Attending physician
    • 2022- 迄今 國立陽明交通大學 醫學院醫學系 助理教授
    經歷:
    • - 臺北榮民總醫院桃園分院 心臟內科 主治醫師
    • - 日本神戶大學附設醫院 心導管室 進修醫師
    • - 臺北榮民總醫院 內科部心臟科 總醫師
    • - 臺北榮民總醫院 內科部 住院醫師
  • 醫療專長
    1. 心臟血管疾病
    2. 心導管檢查與介入性治療
    3. 週邊血管介入性治療
    4. 成人心臟內科
    5. 洗腎廔管血管成型術
    6. 臨床試驗
  • 證照
    中華民國內科專科醫師 中華民國心臟專科醫師 中華民國心臟血管介入專科醫師 中華民國重症醫學專科醫師

[著作]

  1. Zaman A, de Winter RJ, Kogame N, Chang CC, Modolo R, Spitzer E, Tonino P, Hofma S, Zurakowski A, Smits PC, Prokopczuk J, Moreno R, Choudhury A, Petrov  I, Cequier A, Kukreja N, Hoye A, Iniguez A, Ungi I, Serra A, Gil RJ, Walsh S,  Tonev G, Mathur A, Merkely B, Colombo A, Ijsselmuiden S, Soliman O, Kaul U, Onuma Y, Serruys PW; TALENT trial investigators.  Safety and efficacy of a sirolimus-eluting coronary stent with ultra-thin strut for treatment of atherosclerotic lesions (TALENT): a prospective multicentre randomised controlled trial.  Lancet.  2019;393(10175):987-997.
  2. Chang CC, Kogame N, Onuma Y, Byrne RA, Capodanno D, Windecker S, Morel MA, Cutlip DE, Krucoff MW, Stone GW,  Lansky AJ, Mehran R, Spitzer E, Fraser  AG, Baumbach A, Serruys PW. Defining Device Success for Percutaneous Coronary  Intervention Trials: A Position Statement from the European Association of    Percutaneous Cardiovascular Interventions of the European Society of Cardiology. EuroIntervention. 2019; pii: EIJ-D-19-00552
  3. van Geuns RJ, Chang CC, McEntegart MB, Merkulov E, Kretov E, Lesiak M, O'Kane P, Hanratty CG, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R, Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd KG. Bioabsorbable-polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable-polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomized trial. EuroIntervention. 2022;17(18):1467-1476.
  4. Chang CC, Veen KM, Hahn RT, Bogers AJJC, Latib A, Oei FBS, Abdelghani M,  Modolo R, Ho SY,  Abdel-Wahab M, Fattouch K, Bosmans J, Caliskan K, Taramasso M, Serruys PW, Bax JJ, van Mieghem NMDA,  Takkenberg JJM, Lurz P, Modine T, Soliman O. Uncertainties and challenges in surgical and transcatheter tricuspid  valve  therapy: a state-of-the-art expert review.  Eur Heart J. 2019; pii: ehz614.
  5. Chang CC, Lee YH, Chuang MJ, Hsueh CH, Lu YW, Tsai YL, Chou RH, Wu CH, Lu TM, Huang PH, Lin SJ, van Geuns RJ. Agreement Between Invasive Wire-based and Angiography-Based Vessel Fractional Flow Reserve Assessment on Intermediate Coronary Stenoses. Front Cardiovasc Med. 2021;8:707454.

限於篇幅,以上謹為代表著作

回到最上